These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16792862)

  • 1. [The impact of HBeAg positivity/negativity and HBV DNA loads on the prognosis of chronic severe hepatitis B].
    Sun QF; Lü Y; Xu DZ; Lan XY; Liu JY; Sun XJ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):410-3. PubMed ID: 16792862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prospective study of the clinical features and outcome of HBeAg-negative and HBeAg-positive cirrhosis in patients with chronic type B hepatitis].
    Ma H; Guo F; Wei L; Sun Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1832-5. PubMed ID: 17922993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis.
    Ma H; Wei L; Guo F; Zhu S; Sun Y; Wang H
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1250-8. PubMed ID: 18624896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
    Xie Y; Zhao H; Dai WS; Xu DZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations between preS1-antigen, HBV-DNA and HBV serum markers in patients with chronic hepatitis B].
    Zhou H; Jiang CW; Qian JL; Li SJ; Liang JL; Chen XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1184-6. PubMed ID: 18676258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of serum chemokine RANTES level with serum biochemical indices, HBeAg and HBV DNA load in patients with chronic hepatitis B].
    Zhang K; Xu QH; Chen LB; Shu X; Chen N; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):188-90. PubMed ID: 20104774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. e-antigen-negative chronic hepatitis B in Bangladesh.
    Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis].
    Li JQ; Zhuang H; Du H; Wang XH; Duan XZ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):491-3. PubMed ID: 16042881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
    You J; Sriplung H; Chongsuvivatwong V; Geater A; Zhuang L; Huang JH; Chen HY; Yu L; Tang BZ
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of HBeAg positivity and alpha fetoprotein level with the prognosis of chronic severe hepatitis B].
    Peng J; Wang C; Zhang Q; Guo YB; Hou JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1768-70. PubMed ID: 18971167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks].
    He H; Xu ZN; Cai DC; Nai N; Ling N; Zeng WQ; Shi XF; Zhao YR; Zhou Z; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):271-4. PubMed ID: 19403025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
    Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China.
    Zhu L; Tse CH; Wong VW; Chim AM; Leung KS; Chan HL
    J Viral Hepat; 2008 Jun; 15(6):449-58. PubMed ID: 18266648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.